Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progestin-primed ovarian stimulation versus antagonist protocol in women with polycystic ovary syndrome undergoing ART
IRCT20110509006420N18Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2018
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dydrogesterone, cetrorelix and follitropin alfa in female infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Clinical pregnancy rate. Started May 2018; status: completed.
02
Drugs
dydrogesteronecetrorelixfollitropin alfa
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20110509006420N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110509006420N18.